Insights on the Dermatology Diagnostic Devices Global Market to 2027 - by Product Type, End-use and Region
27 mai 2022 08h13 HE
|
Research and Markets
Dublin, May 27, 2022 (GLOBE NEWSWIRE) -- The "Dermatology Diagnostic Devices Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2022-2027" report has been added to...
Global Biomarkers Market Research Report 2021
30 nov. 2021 04h18 HE
|
Research and Markets
Dublin, Nov. 30, 2021 (GLOBE NEWSWIRE) -- The "Biomarkers - Technologies, Markets & Companies" report from Jain PharmaBiotech has been added to ResearchAndMarkets.com's offering. This report...
Global $3.47 Bn Cellular Health Screening Markets to 2028: Focus on Telomere Tests, Oxidative Stress Tests, Inflammation Tests, & Heavy Metals Tests
20 sept. 2021 04h03 HE
|
Research and Markets
Dublin, Sept. 20, 2021 (GLOBE NEWSWIRE) -- The "Global Cellular Health Screening Market Size, Share & Trends Analysis Report by Test Type (Single Test Panels, Multi-test Panels), by Sample Test...
Global Dermatology Diagnostic Devices Market Report 2021: Market Reached a Value of US$ 26.1 Billion in 2020 - Forecast to 2026
18 mai 2021 04h23 HE
|
Research and Markets
Dublin, May 18, 2021 (GLOBE NEWSWIRE) -- The "Dermatology Diagnostic Devices Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2021-2026" report has been added to...
Insights on the Non-Alcoholic Steatohepatitis (NASH) Biomarker Global Market to 2028 - by Type, Industry Verticals and Region
05 mai 2021 04h43 HE
|
Research and Markets
Dublin, May 05, 2021 (GLOBE NEWSWIRE) -- The "Global Non-Alcoholic Steatohepatitis (NASH) Biomarker Market 2021-2028" report has been added to ResearchAndMarkets.com's offering. According to this...
Global Biomarkers 2021 Research Report - Technologies, Markets & Companies
30 avr. 2021 04h23 HE
|
Research and Markets
Dublin, April 30, 2021 (GLOBE NEWSWIRE) -- The "Biomarkers - Technologies, Markets & Companies" report from Jain PharmaBiotech has been added to ResearchAndMarkets.com's offering. This report...
Retrotope Announces Completion of Enrollment in Phase 2 Study of RT001 in Patients with Amyotrophic Lateral Sclerosis (ALS)
21 avr. 2021 07h00 HE
|
Retrotope
LOS ALTOS, Calif., April 21, 2021 (GLOBE NEWSWIRE) -- Retrotope, a clinical-stage biopharmaceutical company focused on the development of novel, first-in-class therapies for degenerative diseases,...
Retrotope to Present at H.C. Wainwright Global Life Sciences Conference
03 mars 2021 16h05 HE
|
Retrotope
LOS ALTOS, Calif., March 03, 2021 (GLOBE NEWSWIRE) -- Retrotope, a clinical-stage biopharmaceutical company focused on the development of novel, first-in-class therapies for degenerative diseases,...
Retrotope Granted Rare Pediatric Disease Designation from FDA for Lead Development Candidate, RT001, in Two Life-Threatening Neurodegenerative Indications
25 févr. 2021 07h00 HE
|
Retrotope
Company Currently Conducting Late-Stage Clinical Trials in Both Infantile Neuroaxonal Dystrophy (INAD) and Friedreich’s Ataxia (FA) RT001 also Granted Fast Track Designation by FDA in FA; Orphan Drug...
Blue California Files Patent on the Use of Ergothioneine as a Support for Oxidative Stress Related Health Conditions, including COVID-19
14 juil. 2020 17h37 HE
|
Blue California Ingredients
Rancho Santa Margarita, Calif and Bedford, Mass., July 14, 2020 (GLOBE NEWSWIRE) -- Blue California, a science-based, innovative ingredient solution provider, has just filed for a patent on...